| Rev Diabet Stud, 2004, 1(3):145-149 | DOI 10.1900/RDS.2004.1.145 |
Charles Sia
Department of Immunology, United Biomedical Inc., 25 Davids Drive, Hauppage, New York 11788, USA, e-mail: csia@mail.ubiasia.com.tw.n/a
Fulltext:
HTML ,
PDF
(191KB)
|
Sutherlandia frutescens limits the development of insulin resistance by decreasing plasma free fatty acid levels
Mackenzie J, Koekemoer T, Venter MV, Dealtry G, Roux S Phytother Res 2009. 23(11):1609-1614 |
|
A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae)
van Wyk BE, Albrecht C J Ethnopharmacol 2008. 119(3):620-629 |
|
A broad review of commercially important southern African medicinal plants
van Wyk BE J Ethnopharmacol 2008. 119(3):342-355 |
|
Anticonvulsant property of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract
Ojewole JA Brain Res Bull 2008. 75(1):126-132 |
|
Sutherlandia frutescens (L) R.Br. - The cancer bush
Latte KP Z Phytother 2005. 26:300-306 |